Correlates of IL-10 and IL-12 concentrations in cervical secretions

Journal of Clinical Immunology

Volumn 23, Issue 3, 2003, Pages 175-183

  Gravitt, Patti E ^a   Hildesheim, Allan ^a   Herrero, Rolando ^b   Schiffman, Mark ^a   Sherman, Mark E ^a   Bratti, M Concepcion ^b   Rodriguez, Ana C ^b   Morera, Lidia A ^b   Cardenas, Fernando ^b   Bowman, Frederick P ^c   Shah, Keerti V ^d   Crowley Nowick, Peggy A ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cervix; Mucosal; Secretions

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; ARTICLE; BODY FLUID; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; INDIVIDUALITY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL CONTRACEPTION; OVULATION; PH; PH MEASUREMENT; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SMOKING; STATISTICAL SIGNIFICANCE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; VAGINA; VIRUS INFECTION; WART VIRUS;

ADULT; CERVIX MUCUS; CERVIX UTERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MUCOUS MEMBRANE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 0037407406     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023305827971     Document Type: Article

References (26)

1. Franco E, Villa L, Sobrinho J, et al.: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180:1415-1423, 1999
2. Nobbenhuis M, Walboomers J, Helmerhorst T, et al.: Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354:20-25, 1999
3. Liaw K-L, Glass A, Manos M, et al.: Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 91:954-960, 1999
4. Brandsma JL: Animal models for HPV vaccine development. Papillomavirus Rep 5:105-111, 1999
5. Selvakumar R, Borenstien EA, Lin Y-L, Ahmed R, Wettstein FO: Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J Virol 69(1):602-605, 1995
6. Suzich JA, Ghim SJ, Palmer-Hill FJ, et al.: Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92:11553-11557, 1995
7. Benton C, Shahidullah H, Hunter JAA: Human papillomavirus in the immunosuppressed. Papillomavirus Rep 3:23-26, 1992
8. Frazer IH, Tindle RW: Cell-mediated immunity to papillomaviruses. Papillomavirus Rep 3(3):53-38, 1992
9. Apple RJ, Erlich HA, Klitz W, Manos MM, Becket TM, Wheeler CM: HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6:157-162, 1994
10. Hildesheim A, Schiffman M, Scott DR, et al.: HLA class I/II allesles and development of HPV-related cervical neoplasia: Results from a case-control study conducted in the United States. CEBP 7(11):1035-1041, 1998
11. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P, Duncan I: Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82(7):1348-1352, 2000
12. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML: Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. CEBP 9(11):1183-1191, 2000
13. Clerici M, Shearer GM, Clerici E: Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm. J Natl Cancer Inst 90(4):261-263, 1998
14. Castle PE, Hildesheim A, Bowman FP, Strickler HD, Walker JL, Pustilnik T, Edwards RP, Crowley-Nowick PA. Cervical concentrations of interleukin-10 and interleukln-12 do not correlate With plasma levels. J Clin Immunol 22(1):23-27, 2002
15. Hildesheim A, Bratti MC, Edwards RP, et al.: Collection of cervical secretions does not adversely affect pap smears taken immediately afterward. Clin Diagn Labs Immunol 5:491-493, 1998
16. Hildesheim A, McShane LM, Schiffman M, et al.: Cytokine and immunoglobulin concentrations in cervical secretions: Reproducibility of the Weck-cel collection instrument and correlates of immune measures J Immunol Methods 225:131-143, 1999
17. Herrero R, Schiffman M, Bratti C, et al.: Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: The Guanacaste Project. Pan Am J Public Health 1:362-375, 1997
18. Garcia-Closas M, Herrero R, Bratti C, Hildesheim A, Sherman ME, Morera LA, Schiffman M: Epidemiologic determinants of vaginal pH. Am J Obstet Gynecol 180:1060-1066, 1999
19. Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 93(4):293-299, 2001
20. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group: Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 92:397-402, 2000
21. Gravitt P, Peyton C, Apple R, Wheeler C: Genotyping of 27 human papillomavirus types using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbio 36:3020-3027, 1998
22. Eschenbach DA, Bekassy S, Blackwell A, Ekgren J, Hallen A, Wathne B: The diagnosis of bacterial vaginosis. Scand J Urol Nephrol 86(Suppl):260-261, 1985
23. Franklin RD, Kutteh WH: Characterization of immunoglobulins and cytokines in human cervical mucus: Influence of exogenous and endogenous hormones. J Reprod Immunol 42(2):93-106, 1999
24. Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki A-B: Cytokine profile in genital tract secretions from female adolescents: Impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 181:939-945, 2000
25. Wilson SB, Kent SC, Horton HF, et al.: Multiple differences in gene expression in regulatory Vα24JαQT cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 97:7411-7416, 2000
26. Joyce S: Natural T cells: Cranking up the immune system by prompt cytokine secretion. Proc Natl Acad Sci USA 97:6933-6935, 2000